WO2007040025A1 - 吸入器および吸入器用マウスピース - Google Patents
吸入器および吸入器用マウスピース Download PDFInfo
- Publication number
- WO2007040025A1 WO2007040025A1 PCT/JP2006/318153 JP2006318153W WO2007040025A1 WO 2007040025 A1 WO2007040025 A1 WO 2007040025A1 JP 2006318153 W JP2006318153 W JP 2006318153W WO 2007040025 A1 WO2007040025 A1 WO 2007040025A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aerosol
- outlet
- exhalation
- mouthpiece
- inhaler
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 claims abstract description 349
- 239000007788 liquid Substances 0.000 claims description 36
- 239000002245 particle Substances 0.000 claims description 28
- 238000000889 atomisation Methods 0.000 claims description 17
- 238000009795 derivation Methods 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 12
- 238000005452 bending Methods 0.000 claims description 6
- 230000002093 peripheral effect Effects 0.000 description 17
- 238000010586 diagram Methods 0.000 description 15
- 239000006199 nebulizer Substances 0.000 description 14
- 210000000214 mouth Anatomy 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 230000009471 action Effects 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000005192 partition Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000003595 mist Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002664 inhalation therapy Methods 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
Definitions
- the present invention relates to an inhaler that discharges aerosol generated by an aerosol generating unit via an aerosol deriving unit and a mouse piece for an inhaler as an aerosol deriving unit used therefor.
- An inhaler is a device used for bronchial disinfection, treatment, and the like, and is widely used in medical institutions and homes as a treatment instrument for treating respiratory diseases such as bronchitis and asthma. .
- an inhaler that atomizes and discharges a drug solution for therapeutic purposes is called an inhalation therapy device.
- Inhalers are roughly classified into three types: a compressor type inhaler, an ultrasonic type inhaler, and an ultrasonic mesh type inhaler based on the atomization principle.
- a compressor-type inhaler mixes liquid to be atomized into compressed air that is sent out by a compressor force, collides the compressed air containing this liquid with a barrier called a baffle, pulverizes the liquid, and thereby forms atomized particles. It is an inhaler of the type that is generated.
- An ultrasonic inhaler is an inhaler of a type in which high-frequency vibration is applied to a liquid by driving an ultrasonic element, and the liquid is atomized using a cavity generated by the high-frequency vibration.
- an ultrasonic mesh inhaler In an ultrasonic mesh inhaler, a vibrating element and a mesh member are arranged to face each other, and a liquid is supplied between them. By driving the vibrating element in this state, the liquid is vibrated, whereby the mesh is applied to the mesh.
- This is an inhaler of a type in which a liquid is made fine by passing the liquid through a provided hole to form atomized particles.
- An inhaler generally includes a device main body including an aerosol generating unit and an aerosol deriving unit.
- the aerosol generation unit is a part that generates aerosol by atomizing a liquid to form atomized particles and applying the atomized particles to the introduced outside air.
- the aerosol deriving unit is a part that discharges the generated aerosol toward the oral cavity or nasal cavity of the user, and a mouthpiece, a nosepiece, a mask, or the like is used.
- the aerosol generating unit has a pressure adjusting port (for adjusting the pressure inside the aerosol)
- a pressure adjusting port for adjusting the pressure inside the aerosol
- an auxiliary outside air introduction port is provided for introducing outside air to the inside of the apparatus body in an auxiliary manner, and an aerosol for introducing the generated aerosol is provided in the aerosol outlet portion.
- a lead-out port is provided.
- the aerosol lead-out unit is provided with an exhalation exhaust port for exhausting exhaled breath exhaled by the user to the outside.
- a check valve is attached to the pressure adjustment port and the exhalation discharge port so as to close the openings.
- check valves are provided so that the user can smoothly breathe without suffocating and can efficiently inhale the aerosol.
- the check valve provided at the pressure adjustment port is generally called an inhalation valve
- the check valve provided at the exhalation discharge port is generally called an exhalation valve.
- One is a usage mode in which the user holds and uses the mouthpiece, and is a usage mode for a user having a relatively large vital capacity.
- the check valve function of the intake valve and the exhalation valve described above has the advantage that the user can inhale with little loss of the generated aerosol.
- the other is a use mode in which the user inhales and inhales aerosol discharged from the mouthpiece without facing the mouthpiece and using it for users with relatively small lung capacity. It is an aspect.
- this mode of use has the disadvantage that the loss of generated aerosol is larger than the mode of use in which the mouthpiece is used in the above-mentioned manner, the vital capacity is small! This is an effective usage mode in that it can be used.
- the check valve function of the inhalation valve and the exhalation valve makes it possible to discharge the generated aerosol from the aerosol outlet with almost no loss. Since the mouthpiece is held in place, not all of the discharged aerosol is sucked and inhaled by the user, and the loss of the aerosol becomes large at that point.
- the inspiratory valve and the expiratory valve are composed of flexible members unlike other components, the handling thereof is complicated, and they are damaged or lost during disassembly and assembly operations. It would be advantageous if it could be abolished with high fear. However, if the intake valve and Z or exhalation valve are simply abolished, the pressure adjustment port and exhalation exhaust loca will cause a large amount of precious aerosol to leak, resulting in a problem that the inhalation efficiency is greatly reduced. Arise.
- FIG. 21 is a longitudinal sectional view of the mouthpiece for an inhaler disclosed in Patent Document 1
- FIG. 22 is a front view of the arrow ⁇ direction force shown in FIG.
- the mouthpiece 250 for inhaler disclosed in Patent Document 1 includes an inhalation part 252 having both ends opened, and an introduction part having one end opened and the other end communicating with the aerosol generating part. 251 and a structure in which the introduction part 251 is provided in the suction part 252 from the opening so that a part of one end opening of the suction part 252 is released to the outside.
- the outlet generation path 204 leading to the aerosol generation part force aerosol outlet 205 is provided in the flow path parts 204A and 204C provided in the introduction part 251 and in the suction part 252.
- the upper part of the channel part 204B provided in the inhalation part 252 and the same in the inhalation part 252
- a flow path portion 204E provided in the.
- a throttle portion 254 is provided in a part of the introduction portion 251 so that the cross-sectional area of the flow path portion 204C is smaller than the cross-sectional area of the flow path portion 204A.
- an aerosol outlet 255 which is the part through which aerosol flows from the inlet 251 to the inhaler 252 is provided in the inhaler 252 and the expiratory outlet 206 is a part located behind the aerosol outlet 255. It is provided at the end of the minute flow path portion 204E.
- FIG. 23 is a longitudinal sectional view of the mouthpiece of the inhaler disclosed in Patent Document 2.
- the mouthpiece 350 for inhaler disclosed in the above-mentioned Patent Document 2 is connected to a lead-out channel 304 which is a discharge channel for atomized particles separated by a partition wall 354 provided in the mouthpiece 350 and for backflow.
- the discharge path 304 is formed so that the opening force at one end communicating with the aerosol generation unit reaches the aerosol discharge port 305 which is the opening at the other end. Is formed from the aerosol outlet 305 to the exhalation outlet 306.
- a lead-out path 304 leading to an aerosol generating part force aerosol outlet 305 is provided in a first tubular part 351 provided in a lower cylindrical part 351 that extends upward with the aerosol generating part force also directed upward.
- the second flow path portion is formed in the upper side tubular portion 352 of the discharge channel extending from the aerosol outlet 305 to the exhalation discharge port 306.
- the upper part of 304B and the flow path part 304E similarly provided in the upper side cylindrical part 352 are comprised.
- the narrowed portion is formed by the partition wall 354 so that the cross-sectional area of the corner flow path portion 304C is smaller than the cross-sectional area of the flow path portion 304A.
- an aerosol outlet 355, which is a part through which the aerosol flows out from the throttle portion to the second flow path portion 304B, is provided in the upper cylindrical portion 352, and the exhalation outlet 306 is more than the aerosol outlet 355. It is provided in the flow path section 304E located on the rear side.
- the aerosol passes through the lower side of the second flow path portion 304B provided in the upper cylindrical portion 352 and is aerosolized.
- the exhaled air passes through the upper side of the second flow path part 304B provided in the upper cylindrical part 352 and reaches the exhaled air outlet 306.
- Prevention and abolition of exhalation valves are realized at the same time.
- Patent Document 1 Japanese Utility Model Publication No. 4 95046
- Patent Document 2 JP-A-5-337183
- the structure of the mouthpiece for an inhaler disclosed in Patent Documents 1 and 2 described above is designed on the assumption that it is used for an ultrasonic type or ultrasonic mesh type inhaler. For this reason, if the mouthpiece for an inhaler having the above structure is applied to a compressor-type inhaler as it is, it is not necessarily a mouthpiece having a suitable shape, and the following problems may occur.
- the mouthpiece When the mouthpiece is lengthened, the time for the aerosol to contact with the wall surface becomes longer, so that the mist-like particles contained in the aerosol become liquid, leading to a decrease in inhalation efficiency.
- the aerosol flow rate may be slower than that of an ultrasonic or ultrasonic mesh inhaler.
- the time for the aerosol to come into contact with the wall surface becomes long. In this throttle part, the liquid of the atomized particles becomes remarkable, and the inhalation efficiency is greatly reduced.
- the lead-out path and the discharge path are stacked in an upward and downward direction by partitioning the lead-out path and the discharge path with a partition wall. Therefore, if the cross-sectional area of these outlet and outlet passages is increased to ensure sufficient aerosol discharge and exhalation discharge, the mouthpiece will increase in size in the vertical direction. . As a result, there is a problem that the shape is difficult to fit in the mouth.
- the present invention has been made to solve the above-described problems, and even if the exhalation valve or the inhalation valve that has been conventionally required is eliminated, the apparatus does not increase in size. It is another object of the present invention to provide an inhaler and an inhaler mouthpiece capable of effectively preventing leakage of a pressure adjusting port and exhalation discharge roca aerosol regardless of the mode of use.
- the inhaler according to the first aspect of the present invention is intended to lead out the aerosol generated inside the device main body to the outside of the device main body, and the derived aerosol is inhaled by the user.
- the apparatus body includes an aerosol generation unit and an aerosol extraction unit.
- the aerosol generation unit includes a storage unit for storing a liquid and a storage unit.
- An atomizing unit that atomizes the stored liquid into atomized particles and applies the atomized atomized particles to the outside air introduced into the apparatus main body.
- the aerosol deriving unit includes an aerosol deriving port for deriving the generated aerosol to the outside of the apparatus main body, a deriving path for guiding the generated aerosol to the aerosol generating unit force, the aerosol deriving port, and the aerosol. And an exhalation exhaust port for exhausting the exhalation of the user introduced from the deriving port to the deriving route.
- the outlet passage includes a first flow path portion extending in the first direction toward the aerosol generating portion force, a second passage extending in the second direction intersecting the first direction, and reaching the aerosol outlet port. 2 channel portions and a corner one channel portion connecting the first channel portion and the second channel portion.
- the aerosol guide part of the part defining the corner channel part has a curved part formed by bending a wall surface on the side intersecting with the center line of the first channel part.
- the exhalation discharge port is provided on a wall surface at a position that deviates in a circumferential direction from a wall surface on the side where the curved portion of the aerosol outlet portion is provided and that defines the second flow path portion.
- the wall surface at a position shifted in the circumferential direction from the wall surface on the side where the curved portion is provided means the wall surface of the lead-out path formed so as to surround the central axis of the second flow path portion.
- the wall surface of the portion not including the wall surface of the outlet path on the side where the curved portion is provided is meant.
- the first flow passage can be used during the inhalation. It is possible to smoothly guide the aerosol flowing through the flow path part to the second flow path part, and to collect the aerosol air flow on the wall surface side where the curved part is provided and guide it to the second flow path part. Therefore, it is possible to effectively prevent the leakage of the aerosol exhalation location by providing an exhalation exhaust port on the wall surface at a position shifted in the circumferential direction from the wall surface on the side where the curved portion is formed. .
- the exhalation discharge port is located at a position near the corner channel portion of the aerosol lead-out portion of the portion defining the second channel portion. It is preferable to be established.
- the aerosol that has flowed through the first flow path portion gathers on the wall surface side where the curved portion is provided, particularly in the portion near the corner flow path portion of the second flow path portion. 2 Providing near the corner flow path portion of the aerosol lead-out portion that defines the flow path portion can reliably prevent the aerosol from leaking out from the exhalation outlet.
- the aerosol lead-out portion displays the cross-sectional area of the second flow path portion at the position where the exhalation discharge port is provided.
- the throttle portion it is preferable to have a throttle portion that decreases toward the air outlet, and the throttle portion is located on the inner side of the exhalation outlet in the portion where the exhalation outlet of the aerosol outlet portion is provided. It is preferable.
- the airflow of the aerosol can be collected at the central position in the radial direction of the second flow path portion by the throttle portion, so that the expiratory discharge loca can also keep the airflow of the aerosol away Therefore, it is possible to effectively prevent the leakage of aerosol from the exhalation outlet.
- the curved portion has a dome shape, in which case the throttle portion is the dome-shaped curved portion. It is preferred to be composed of a part of
- the curved portion and the throttle portion are integrally formed in the dome-shaped portion, so that the smooth air that does not unnecessarily complicated the shape of the lead-out path is formed. Mouth sol derivation and exhalation can be achieved.
- the exhalation exhaust port sandwiches a plane including the center line of the first flow path portion and the center line of the second flow path portion. Position of the above air mouth It is preferable that a pair of sol outlets is provided.
- the inhaler according to the second aspect of the present invention is intended to lead out the aerosol generated inside the device main body to the outside of the device main body, and the derived aerosol is inhaled by the user.
- the apparatus body includes an aerosol generation unit and an aerosol extraction unit.
- the aerosol generation unit atomizes the liquid stored in the storage unit and the liquid stored in the storage unit into atomized particles, and applies the atomized atomized particles to the outside air introduced into the apparatus main body. Including an atomizing section.
- the aerosol deriving unit includes an aerosol deriving port for deriving the generated aerosol to the outside of the apparatus main body, a deriving path for guiding the generated aerosol to the aerosol generating unit force, the aerosol deriving port, and the aerosol. And an exhalation exhaust port for exhausting the exhalation of the user introduced from the deriving port to the deriving route.
- the portion of the aerosol leading portion that defines the lead-out path has a throttling portion that reduces the cross-sectional area of the lead-out path toward the aerosol lead-out port at a position where the breath exhaust port is provided.
- the portion of the aerosol lead-out portion where the exhalation outlet is provided is located on the inner side of the exhalation outlet.
- the throttle portion in the aerosol outlet portion where the exhalation outlet is provided by providing the throttle portion in the aerosol outlet portion where the exhalation outlet is provided, the airflow of the aerosol is collected at the center position in the radial direction of the second flow path portion at the time of inhalation. Therefore, the expiratory discharge loca can also keep the aerosol airflow away, and can effectively prevent the leakage of the aerosol from the expiratory outlet. In addition, when exhalation is discharged, exhalation is smoothly discharged from the exhalation discharge port, so that it is possible to prevent the aerosol from leaking out the exhalation discharge locus regardless of the usage state.
- the aerosol lead-out part can be downsized. Furthermore, on the lead-out path Since the exhaled exhaled air can be effectively discharged, it is not necessary to provide an intake valve at the pressure adjustment port provided in the aerosol generating unit, and the intake valve can be eliminated.
- the aerosol generating part further includes a pressure adjusting port for adjusting the pressure inside the apparatus main body.
- the cross-sectional area of the path from the pressure adjusting port to the atomizing portion is reduced so that the flow resistance is higher in a specific part than in other parts of the path. It is preferable to include a labyrinth portion that is bent at least once.
- the aerosol leading portion is detachably attached to the aerosol generating portion.
- the mouthpiece for inhaler according to the first aspect of the present invention is detachably attached to the aerosol generating part of the inhaler, and the aerosol generated by the aerosol generating part is placed outside the aerosol generating part.
- an exhalation exhaust port for exhausting the exhalation of the user introduced from the aerosol outlet to the outlet path.
- the lead-out path extends from the aerosol generating part in a first direction extending in the first direction and in a second direction intersecting the first direction and reaches the aerosol lead-out port.
- the portion defining the corner channel portion is provided with a curved portion by bending a wall surface on the side intersecting the center line of the first channel portion.
- the exhalation discharge port is provided on the wall surface at a position that deviates in the circumferential direction from the wall surface on the side where the curved portion is provided and that defines the second flow path portion.
- the wall surface at a position shifted in the circumferential direction from the wall surface on the side where the curved portion is provided means the wall surface of the outlet channel formed so as to surround the central axis of the second flow channel portion. This means the wall surface of the part 1, not including the wall surface of the lead-out path on the side where the curved portion is provided.
- the first flow rate can be obtained during inhalation. It is possible to smoothly guide the aerosol flowing through the passage part to the second flow path part, and to collect the aerosol air flow on the wall surface side where the curved part is provided and guide it to the second flow path part.
- the exhalation discharge port on the wall surface at a position shifted in the circumferential direction from the wall surface on the side where the curved portion is formed, leakage of aerosol from the exhalation discharge port can be effectively prevented.
- the exhalation outlet is provided at a position near the corner channel portion of the portion defining the second channel portion. It is preferable.
- the aerosol that has flowed through the first flow path portion gathers on the wall surface side where the curved portion is provided, particularly in the portion near the corner flow path portion of the second flow path portion. 2 By providing it near the corner flow path, which defines the flow path, it is possible to reliably prevent aerosol leakage from the exhalation outlet.
- the cross-sectional area of the second flow path portion is directed toward the aerosol outlet port at a position where the exhalation outlet port is provided.
- the portion provided with the air discharge port is located inside the exhalation discharge port.
- the airflow of the aerosol can be collected at the central position in the radial direction of the second flow path portion by the throttle portion, so that the expiratory discharge loca can also keep the airflow of the aerosol away Therefore, it is possible to effectively prevent the leakage of aerosol from the exhalation outlet.
- the curved portion force S has a dome shape. It is preferable to be composed of a part of the curved part.
- the curved portion and the throttle portion are integrally formed by the dome-shaped portion, so that the smooth air that does not make the shape of the lead-out path more complicated than necessary. Mouth sol derivation and exhalation can be achieved.
- the exhalation outlet includes a plane including the center line of the first flow path portion and the center line of the second flow path portion. It is preferable that a pair is provided at a position between the two.
- a mouthpiece for an inhaler is detachably attached to an aerosol generation unit of the inhaler, and the aerosol generated inside the aerosol generation unit is used as the aerosol generation unit.
- An aerosol outlet for deriving the aerosol generated in the aerosol generation unit to the outside, and a deriving path for leading the generated aerosol to the aerosol generation unit force and the aerosol outlet
- an exhalation exhaust port for exhausting the exhalation of the user introduced from the aerosol outlet to the outlet path.
- a throttling portion for reducing the cross-sectional area of the lead-out path toward the aerosol outlet is provided at the position where the exhalation outlet is provided.
- the throttling portion is located on the inner side of the exhalation discharge port in a portion where the exhalation discharge port is provided. [0050] As described above, by providing the throttle portion in the portion where the exhalation discharge port is provided, the airflow of the aerosol can be collected at the central position in the radial direction of the second flow path portion during inhalation. It becomes possible to keep the airflow of the expiratory discharge aerosol aerosol away, and it is possible to effectively prevent the leakage of the aerosol from the expiratory outlet. Further, when exhaling, since exhalation is smoothly discharged from the exhalation discharge location, it is possible to prevent the aerosol from leaking out the expiration discharge location regardless of the use mode.
- the exhalation valve or in addition to the exhalation valve can be eliminated in the inhaler, and the exhalation valve can be eliminated in the inhaler mouthpiece. It is possible to effectively prevent the aerosol of the pressure adjusting port and the expiratory outlet force aerosol from leaking without increasing the size of the mouthpiece and the mouthpiece for the inhaler.
- FIG. 1 is an external view showing a device configuration of an inhaler according to a first embodiment of the present invention.
- FIG. 2A is a side view showing the structure of the nebulizer of the inhaler according to the first embodiment of the present invention.
- FIG. 2B is a front view showing the structure of the nebulizer of the inhaler according to the first embodiment of the present invention.
- FIG. 3 is an exploded perspective view showing an assembly structure of a nebulizer according to Embodiment 1 of the present invention.
- FIG. 4 is a cross-sectional view of the nebulizer of the inhaler according to the first embodiment of the present invention.
- ⁇ 5] A perspective view of an inhaler mouthpiece according to the first embodiment of the present invention.
- FIG. 6 is a bottom view of the mouthpiece for inhaler according to the first embodiment of the present invention.
- ⁇ 7 A perspective view of an inhaler mouthpiece according to the first embodiment of the present invention.
- FIG. 8 is a cross-sectional view of the mouthpiece for inhaler according to the first embodiment of the present invention.
- FIG. 9 is a cross-sectional view of the mouthpiece for inhaler according to the first embodiment of the present invention.
- FIG. 10 is a cross-sectional view of the mouthpiece for inhaler according to the first embodiment of the present invention.
- FIG. 11A is a diagram showing an air flow during inhalation in the mouthpiece for inhaler according to the first embodiment of the present invention.
- FIG. 11B is a diagram showing an air flow during inhalation in the mouthpiece for inhaler according to the first embodiment of the present invention.
- FIG. 11C is a diagram showing an air flow during inhalation in the mouthpiece for inhaler according to the first embodiment of the present invention.
- Fig. 12 is a diagram showing the flow of air flow when exhaling in the inhaler mouthpiece according to Embodiment 1 of the present invention.
- FIG. 13 is a cross-sectional view of the mouthpiece for inhaler according to the first embodiment of the present invention.
- FIG. 14 is a perspective view of an inhaler mouthpiece according to the second embodiment of the present invention.
- FIG. 15 is a diagram showing the flow of airflow during inhalation in the mouthpiece for inhaler according to the second embodiment of the present invention.
- FIG. 16 is a diagram showing the flow of air flow when exhaling air in the mouthpiece for inhaler according to the second embodiment of the present invention.
- FIG. 17 is a perspective view of an inhaler mouthpiece according to the third embodiment of the present invention.
- FIG. 18 is a cross-sectional view of an inhaler mouthpiece according to the third embodiment of the present invention.
- FIG. 19 is a diagram showing the flow of airflow during inhalation in the mouthpiece for inhaler according to the third embodiment of the present invention.
- FIG. 20 is a diagram showing the flow of air flow when exhaling air in the mouthpiece for inhaler according to Embodiment 3 of the present invention.
- FIG. 21 is a longitudinal sectional view showing a configuration example of a conventional mouthpiece for an inhaler.
- FIG. 22 is a front view of the mouthpiece for inhaler shown in FIG. 21.
- FIG. 23 is a longitudinal sectional view showing another configuration example of a conventional mouthpiece for an inhaler.
- FIG. 1 is an external view showing a device configuration of an inhaler according to Embodiment 1 of the present invention.
- the inhaler 1 according to the present embodiment includes a compressor 10, a tube 20, and a nebulizer 100 that is a device main body.
- the compressor 10 is connected to the nebulizer 100 via a tube 20 having flexibility, and sends compressed air pressurized through the tube 20 to the nebulizer 100.
- FIGS. 2A and 2B are diagrams showing a detailed structure of the nebulizer of the inhaler shown in FIG. 1, FIG. 2A is a side view, and FIG. 2B is a front view.
- FIG. 3 is an exploded perspective view showing the assembly structure of the nebulizer shown in FIGS. 2A and 2B.
- the nebulizer 100 includes a case body 110, an atomization portion forming body 120, a flow path forming body 130, a cap body 140, and a mouthpiece 150A. ing.
- the case body 110, the atomization part formation body 120, the flow path formation body 130, and the cap body 140 are obtained by atomizing the liquid into mist-like particles and applying the mist-like particles to the introduced outside air.
- Producing aerosol The aerosol generator is configured.
- the mouthpiece 150A constitutes an aerosol lead-out unit that discharges the generated aerosol toward the user's oral cavity, nasal cavity, and the like.
- the case body 110 has a bottomed cylindrical shape, and the atomizing portion forming body 120 is accommodated in the inside of the case body 110.
- the flow path forming body 130 is attached to the upper portion of the case body 110 so as to close the upper surface opening of the case body 110.
- the cap body 140 is attached to the flow path forming body 130 so as to cover an opening provided on the upper surface of the flow path forming body 130.
- the mouthpiece 15 OA is detachably attached to a connection part 132 provided on the upper part of the flow path forming body 130.
- the case body 110, the atomization section forming body 120, the flow path forming body 130, the cap body 140 and the mouthpiece 150A can be disassembled and assembled with each other. It is configured so that it can be easily disinfected.
- a locking recess 119 is formed by providing a groove at a predetermined position on the inner peripheral surface of the case body 110, and a lower portion of the outer peripheral surface of the flow path forming body 130.
- a locking projection 139 is provided at a predetermined position by providing a protrusion. The locking recess 119 and the locking projection 139 serve as a locking portion when the flow path forming body 130 is attached to the case body 110.
- a mark 118 is provided at a predetermined upper position on the outer peripheral surface of the case body 110, and a lower predetermined position on the outer peripheral surface of the flow path forming body 130 is provided.
- the mark 138 is provided. These marks 118 and 138 are indices indicating the mounting position of the flow path forming body 130 with respect to the case body 110.
- the flow path forming body 130 is placed on the case body 110 so that the mark 118 and the mark 138 face each other. Install.
- the atomizing part forming body 120 includes a baffle 122 and a liquid suction pipe forming part 124.
- the kaffle 122 has a cylindrical shape, and the liquid suction pipe forming portion 124 is configured by a conical cylindrical body having an open end.
- the liquid suction pipe forming section 124 has a lower end of the tip force baffle 122 and is opposed to it!
- the flow path forming body 130 includes a connection portion 132, an opening 133, and an intake pipe portion 134.
- the connection part 132 is a part to which the mouthpiece 150A is connected as described above, and protrudes upward at a predetermined position on the upper part of the flow path forming body 130.
- the opening 133 is a part into which the lower part of the cap body 140 is fitted, and is provided at a predetermined position on the upper surface of the flow path forming body 130.
- the intake pipe part 134 is a part for guiding outside air introduced from a pressure adjusting port 101 (see FIGS. 2A and 2B), which will be described later, to an atomizing part, which will be described later. It is projecting toward.
- a concave portion 142 is provided at a predetermined position on the outer peripheral surface 141 of the cap body 140.
- the lower portion of the concave portion 142 is disposed so as to face the inner peripheral surface of the flow path forming body 130 in a state where the cap body 140 is attached to the flow path forming body 130, and thereby the outer peripheral surface 144 of the cap body 140.
- the inner peripheral surface of the flow path forming body 130 constitute the pressure adjustment port 101.
- the mouthpiece 150A also has a cylindrical member that is bent at a substantially central portion, and a lead-out path 104 (see FIG. 4) to be described later is provided inside. Is provided. An aerosol outlet 105 for discharging aerosol is provided at the tip of the mouthpiece 150A. In addition, at a predetermined position on both sides of the mouthpiece 150A, a pair of exhalation exhaust ports 106 for exhausting exhalation are provided. The detailed shape of the mouthpiece 150A will be described later.
- FIG. 4 is a cross-sectional view taken along the line IV-IV shown in FIG. 2B of the nebulizer of the inhaler according to the present embodiment.
- FIG. 4 the internal structure of nebulizer 100 and the flow of airflow in the present embodiment will be described in detail.
- a compressed air introduction pipe portion 114 for introducing the compressed air delivered from the compressor 10 into the case body 110 extends in the vertical direction. It is arranged like this.
- the above-described tube 20 is attached to the lower end portion of the compressed air introduction pipe portion 114.
- the upper end portion of the compressed air introduction pipe portion 114 is formed in a tapered shape, and faces the baffle 122 of the atomization portion forming body 120.
- a reservoir 116 is provided around the portion of the case body 110 where the compressed air introduction pipe 114 is formed.
- the storage unit 116 temporarily stores a liquid 30 such as water, saline, or a chemical solution.
- a liquid absorption pipe forming part 124 of the atomizing part forming body 120 is disposed facing the upper end of the compressed air introducing pipe part 114 from above.
- the inner peripheral surface of the liquid suction pipe forming part 124 is positioned and arranged at a predetermined distance from the outer peripheral surface of the compressed air introduction pipe part 114, and the lower end thereof reaches the vicinity of the bottom surface of the storage part 116 described above.
- the This liquid absorption pipe forming section 124 and the compressed air guide A liquid absorption pipe is configured by a gap between the inlet pipe section 114, and the liquid 30 stored in the storage section 116 reaches the vicinity of the atomization section described later by the action of negative pressure generated by blowing compressed air described later. .
- the atomizing portion is formed between the upper end portion of the compressed air introduction pipe portion 114 and the baffle 122 described above.
- the compressed air introduced into the compressed air introduction pipe section 114 by the compressor 10 is sprayed from the upper end portion of the compressed air introduction pipe section 114 toward the baffle 122.
- the liquid 30 sucked and raised to the vicinity of the atomization part by the action of the negative pressure generated in the atomization part is jetted to the atomization part by the action of the negative pressure described above, and together with the compressed air It is sprayed toward the baffle 122.
- the liquid 30 collides with the baffle 122 to become fine droplets and become mist-like particles, and the mist-like particles are introduced into the case body 110 (the outside air introduced by the compressor 10 and the outside air). Aerosol is generated by being applied to the outside air introduced from the pressure adjusting port 101 based on the expiration operation of the user.
- the flow path forming body 130 is positioned and arranged.
- the flow path forming body 130 partitions the space inside the case body 110 and forms a flow path through which airflow flows. More specifically, the space inside the case body 110 is divided into a central part and a peripheral part by an intake pipe part 134 provided at the lower part of the flow path forming body 130, and the introduction path 102 is defined by the central part.
- the aerosol conveyance path 103 is constituted by the peripheral portion.
- the introduction path 102 is the outside air that has flowed from the pressure adjustment port 101 that is configured by a gap between the cap body 140 fitted in the opening 133 provided on the upper surface of the flow path forming body 130 and the flow path forming body 130.
- the aerosol transport path 103 is a flow path for guiding the aerosol generated in the atomization section to the mouthpiece 150A.
- the intake pipe portion 134 is disposed so as to cover the side of the atomizing portion.
- the mist particles having a relatively large particle diameter come into contact with the inner peripheral surface of the intake pipe portion 134 to contact the liquid.
- the inner peripheral surface of the intake pipe part 134 is returned to the storage part 116.
- atomized particles with a relatively small particle size The liquid flows into the aerosol transport path 103 without liquid. Therefore, only the fine mist particles suitable for inhalation can be selectively guided to the mouthpiece 150A.
- a chemical solution is nebulized and inhaled, it is important to obtain an aerosol containing atomized particles having a particle size suitable for treatment, and it is very significant to adopt the above configuration.
- the mouthpiece 150A is attached to the connecting portion 132 provided on the upper surface of the flow path forming body 130, whereby the aerosol transport path 103 provided in the case body 110 is provided. Then, the lead-out path 104 provided inside the mouthpiece 150A communicates.
- the flow of the airflow when the user holds the mouthpiece 150A and inhales the aerosol is as follows.
- the outside air is introduced into the case body 110 by the compressor 10, and aerosol is constantly generated in the atomizing portion.
- the user performs an intake operation to inhale and take in the aerosol, so that the internal space of the case body 110 becomes negative pressure through the lead-out path 104 of the mouthpiece 150A.
- outside air is taken into the case body 110 from the pressure adjustment port 101.
- the taken-in outside air reaches the atomization section through the introduction path 102 formed inside the intake pipe section 134.
- inhaler 1 is characterized by the shape of mouthpiece 150A as will be described later, so that it is effective for aerosol to leak out from exhalation outlet 106 of mouthpiece 150A during inhalation. Can be prevented.
- exhalation is introduced into the outlet path 104 of the mouthpiece 150A.
- the exhaled air introduced into the lead-out path 104 is discharged to the outside from the exhalation discharge port 106 provided in the mouse piece 150A.
- the inhaler 1 in the embodiment is characterized by the shape of the mouthpiece 150A as will be described later, almost all the exhaled air introduced into the lead-out path 104 is effectively discharged from the exhalation outlet 106 to the outside. Will be discharged. Therefore, the exhaled air is prevented from flowing back to the aerosol conveyance path 103 side, that is, inside the case body 110.
- the flow is almost the same as the flow of airflow during inhalation when the user holds the mouthpiece 150A and inhales.
- the inside of the case body 110 does not become negative pressure due to the intake operation of the user, only the compressed air sent from the compressor 10 contributes to the intake of the outside air and the derivation of the aerosol.
- the aerosol is continuously discharged from the aerosol outlet 105.
- inhaler 1 in the present embodiment is characterized by the shape of mouse piece 150A as will be described later, so that aerosol leaks outside from exhalation outlet 106 of mouthpiece 150A even in the above-described use mode. Can be effectively prevented.
- FIGs. 5 to 10 are views showing the shape of the mouthpiece for inhaler in the present embodiment.
- Fig. 5 is a perspective view of the mouthpiece for inhaler
- Fig. 6 is a bottom view of the force in the direction of arrow VI shown in Fig. 5
- Fig. 7 is also the force in the direction of arrow VII shown in Fig. 5.
- FIG. 8 is a cross-sectional view taken along line VIII-VIII shown in FIGS. 6 and 7
- FIG. 9 is a cross-sectional view taken along line IX-IX shown in FIG.
- FIG. 10 is a cross-sectional view taken along line X—X shown in FIG.
- the shape of the mouthpiece 150A for inhaler will be described in detail with reference to these drawings.
- inhaler mouthpiece 150A is connected to connecting portion 132 of flow path forming body 130, and has a lower cylindrical portion 151 extending upward.
- the cylindrical member has an upper cylindrical portion 152 that extends obliquely forward from the lower cylindrical portion 151.
- a first flow path portion 104A extending upward (first direction 104a) is formed inside the lower cylindrical portion 151, and an obliquely upper portion is formed inside the upper cylindrical portion 152.
- a second flow path portion 104B extending in the (second direction 104b) direction is formed.
- a corner channel portion 104C that connects the first channel portion 104A and the second channel portion 104B is formed.
- the first flow path portion 104A, the second flow path portion 104B, and the corner flow path portion 104C constitute a lead-out path 104 for deriving aerosol.
- an opening for communicating the above-described aerosol conveyance path 103 and the first flow path section 104A is located at the lower end of the lower cylindrical section 151.
- an aerosol outlet 105 for leading the aerosol to the outside is located at the tip of the upper cylindrical portion 152.
- a wall that intersects the center line of the first flow path portion 104A of the mouthpiece 150A that defines the corner flow path portion 104C has a wall that defines the first flow path portion 104A and a second flow path portion 104B.
- a bending portion 153 configured to bend smoothly so as to connect to a wall that defines the position is located.
- the curved portion 153 has a dome shape, and an aerosol outlet 155 is formed by partially cutting away the portion facing the aerosol outlet 105.
- the portion defining the aerosol outlet 155 of the curved portion 153 having a dome-like shape constitutes a throttle portion 154 that reduces the cross-sectional area of the second flow path portion 104B toward the aerosol outlet 105.
- the Exhalation discharge ports 106 are respectively provided on both side surfaces of the upper cylindrical portion 152 at a position corresponding to the portion where the throttle portion 154 is provided. Therefore, the throttle portion 154 is located inside the exhalation exhaust port 106 at the portion where the exhalation exhaust port 106 of the second flow path unit 104B is provided.
- FIGS. 11A to 11C are diagrams showing the flow of airflow during inhalation in the mouthpiece for inhaler in the present embodiment.
- FIG. 12 is a diagram showing the flow of air flow when exhalation is discharged in the mouthpiece for inhaler according to the present embodiment.
- FIG. 11A and FIG. 11C show the flow of air flow in the sections corresponding to FIG. 9, FIG. 8, and FIG. 10, respectively, and
- FIG. 12 shows the section corresponding to FIG. It shows the flow of the air flow at.
- FIGS. 11A to 11C and FIG. 12 all assume that the user holds the mouthpiece and inhales, but the user faces the mouthpiece without holding the mouthpiece.
- the flow of airflow when the user holds the mouthpiece 150A and inhales aerosol is as follows. As shown in FIGS. 11A and 11B, the aerosol that has flowed into the first flow path 104A of the mouthpiece 150A from the aerosol conveyance path 103 flows upward and reaches the corner flow path 104C. The aerosol that reaches the corner channel portion 104C flows along the dome-shaped curved portion 153, passes through the aerosol outlet 155, and reaches the second channel portion 104B.
- the aerosol is smoothly introduced from the first flow path portion 104A to the second flow path portion 104B due to the presence of the curved portion 153, and the aerosol in the corner one flow path portion 104C.
- the flow of is not disturbed.
- the aerosol is squeezed by the throttle portion 154, which is a part of the dome-shaped curved portion 153, and collected at the center position in the radial direction of the second flow path portion 104B.
- the second flow path portion 104B is collected on the wall surface on the side where the curved portion 153 is formed.
- the aerosol passes through a position far away from the exhalation exhaust port 106 in the portion where the exhalation exhaust port 106 is provided, and in the vicinity of the portion where the exhalation exhaust port 106 is provided (in region A in FIG. 11C). Since negative pressure is generated in the portion (shown) and outside air is introduced from the exhalation exhaust port 106, it is possible to reliably prevent the aerosol from being leaked from being leaked from the exhalation exhaust port 106.
- the aerosol that has flowed into the second flow path portion 104B spreads in a fan shape, and is then led out from the aerosol outlet 105 to the user's oral cavity.
- the exhalation discharge port 106 is provided at a position near the corner channel portion 104C of the mouthpiece 150A that defines the second channel portion 104B.
- the exhaled air introduced into the second flow path portion 104B of the mouthpiece 150A by the user exhaling the exhaled air is, as shown in FIG. 12, the second flow path portion 104B. It is discharged to the outside from the exhalation discharge port 106 provided in. At this time, the aerosol is about to flow into the second flow path portion 104B from the aerosol outlet 155 by the feeding pressure of the compressor 10. However, since the flow pressure of exhalation is usually higher, there is no concern that the aerosol leaks from the exhalation outlet 106.
- the flow is almost the same as the flow of air flow when inhaling when the user holds the mouthpiece 150A and inhales.
- the inside of the case body 110 does not become negative pressure due to the intake operation of the user, only the compressed air sent from the compressor 10 contributes to the intake of the outside air and the derivation of the aerosol.
- the aerosol is continuously discharged from the aerosol outlet 105.
- the mouthpiece 150A in the present embodiment also has a force S that effectively prevents the aerosol from leaking at this time, and the mechanism is the case where the above-mentioned user holds the mouthpiece 150A and inhales it. It is the same as that of inhalation.
- the aerosol can leak out from the exhalation exhaust port 106 regardless of the usage mode. Can be prevented. Therefore, the inhalation efficiency can be maintained high without providing the exhalation valve at the exhalation outlet 106, the number of parts can be reduced, and the workability at the time of cleaning and disinfection is dramatically improved. Manufacturing costs can be greatly reduced. In addition, since there is no need to provide a discharge path for exhalation excluding the aerosol lead-out path 104, which does not require a particularly long throttle portion in the flow path, Can be reduced in size compared to the conventional case.
- the exhaled air that has flowed into the outlet channel 104 can be effectively discharged from the exhaled air discharge port 106, it is not necessary to provide an intake valve at the pressure adjustment port 101 provided in the aerosol generation unit. It is also possible to abolish.
- FIG. 13 is a cross-sectional view of the mouthpiece for inhaler according to the present embodiment described above, taken along the line XIII— ⁇ shown in FIG.
- exhalation exhaust port 106 sandwiches plane 180 including the respective center lines of first channel portion 104A and second channel portion 104B.
- a pair is provided at the position, that is, at the side.
- This portion is located at a position shifted from the wall surface on the side that intersects the center line of the first flow path portion 104A (the wall surface of the portion surrounded by the chain line B1 in FIG. 13) in the circumferential direction and the second channel. It is a part of the wall surface (the wall surface surrounded by the chain line B2 in FIG.
- the second flow path section 104B is used for the purpose of ensuring a large opening area of the exhalation outlet in order to more securely exhaust the exhalation from the outlet path 104 to the outside.
- a pair of exhalation outlets 106 is provided on the side surface of this side, but it is not always necessary to provide an exhalation outlet on this side part. Also good.
- FIG. 14 is a perspective view of an inhaler mouthpiece according to Embodiment 2 of the present invention.
- FIG. 15 is a diagram showing the flow of airflow during inhalation in the mouthpiece for inhaler in the present embodiment
- FIG. 16 is a diagram showing the flow of airflow during exhalation.
- the structure of inhaler mouthpiece 150B and the flow of airflow in the present embodiment will be described with reference to these drawings. Note that the inhaler mouthpiece 150B in the present embodiment has a structure similar to that of the inhaler mouthpiece 150A in the above-described first embodiment, and therefore the same reference numerals are given to the same portions in the figure. ,That The description will not be repeated here.
- inhaler mouthpiece 150 B in the present embodiment is similar to inhaler mouthpiece 150 A in the first embodiment described above, and includes lower side tubular portion 151 and an upper portion.
- a cylindrical member having a side cylindrical part 152, and a flow path part 104 that also has the force of the first flow path part 104A, the second flow path part 104B, and the corner flow path part 104C are provided therein.
- the wall that defines the first flow path portion 104A and the second flow path portion 104B are provided on the wall of the mouthpiece 150B that defines the corner flow path portion 104C on the side that intersects the center line of the first flow path portion 104A.
- a curved portion 153 formed by bending so as to smoothly connect with a prescribed wall is located.
- an exhalation exhaust port 106 for exhausting exhalation is provided at a position near the corner channel portion 104C on the lower surface side of the mouthpiece 150B that defines the second channel portion 104B.
- the throttle part is particularly formed!
- the airflow when the user holds the mouthpiece 150B and inhales the aerosol is as shown in FIG. That is, the aerosol flowing into the first flow path portion 104A flows upward, reaches the corner flow path portion 104C, flows along the curved portion 153, and then passes through the second flow path portion 104B. It is discharged from the aerosol outlet 105. At this time, the aerosol is smoothly introduced from the first flow path portion 104A to the second flow path portion 104B due to the presence of the curved portion 153, and the aerosol flows in the corner flow path portion 104C. It will not be disturbed.
- the aerosol is collected on the wall surface on the side where the curved portion 153 of the second flow path portion 104B is formed, the aerosol is far away from the exhalation exhaust port 106 at the portion where the exhalation exhaust port 106 is provided. It will pass through that position. Therefore, a negative pressure is generated in the vicinity of the portion where the exhalation exhaust port 106 is provided (portion indicated by region C in FIG. 15), and this causes outside air to be introduced from the exhalation exhaust port 106, so that the aerosol is expelled. Aerosol waste that can be prevented from leaking through the outlet 106 is reliably prevented.
- the compressor 10 The force at which the aerosol tries to flow into the second flow path portion 104B due to the pressure supply.
- the flow pressure of the exhalation is greater, so there is no fear of the aerosol leaking from the exhalation outlet 106.
- the exhalation flows into the space inside the case body 110, thereby adjusting the pressure. No aerosol leaks out of mouth 101.
- the mouthpiece 150B according to the present embodiment is also capable of effectively preventing the aerosol from leaking at this time.
- the mechanism is that the above-mentioned user holds the mouthpiece 150B and inhales it. Same as inhalation in case.
- the mouthpiece 150B for an inhaler as in the present embodiment since the mouthpiece 150B for an inhaler as in the present embodiment is used, it is possible to prevent the aerosol from leaking from the exhalation outlet 106 regardless of the usage mode. Therefore, it is possible to maintain high inhalation efficiency without providing an exhalation valve at the exhalation outlet 106, and it is possible to reduce the number of parts, and the workability during cleaning and disinfection is dramatically improved. At the same time, manufacturing costs can be significantly reduced. In addition, since it is not necessary to provide a discharge path for exhaling breath separately from the aerosol lead-out path 104 that does not require any restriction, a mouthpiece can be made smaller than before.
- the exhaled air that has flowed into the lead-out path 104 can be effectively discharged from the exhaled air discharge port 106, it is not necessary to provide an intake valve at the pressure adjustment port 101 provided in the aerosol generation unit. It can also be abolished.
- FIG. 17 is a perspective view of an inhaler mouthpiece according to Embodiment 3 of the present invention.
- FIG. 18 is a cross-sectional view.
- FIG. 19 is a diagram showing the flow of airflow during inhalation in the mouthpiece for inhaler in the present embodiment
- FIG. 20 is a diagram showing the flow of airflow during exhalation.
- the structure of the mouthpiece 150C for inhaler and the flow of airflow in the present embodiment will be described with reference to these drawings.
- the mouthpiece 150C for inhaler in the present embodiment has a structure similar to that of the mouthpiece 150A for inhaler in the above-described first embodiment, and therefore V is the same for the same part in the figure. The reference is attached, and the explanation is not repeated here! /.
- the inhaler mouthpiece 150C in the present embodiment is similar to the inhaler mouthpiece 150A in the first embodiment described above, with the lower cylindrical portion 151 and the upper portion A cylindrical member having a side cylindrical part 152, and a flow path part 104 that also has the force of the first flow path part 104A, the second flow path part 104B, and the corner flow path part 104C are provided therein.
- the portion that defines the corner channel portion 104C is not provided with a curved portion and has a bent shape. .
- a portion near the corner channel portion 104C on the both side surfaces of the mouthpiece 150C defining the second channel portion 104B is bent toward the inside so that the second flow
- a throttle part 154 for reducing the cross-sectional area of the road part 104B toward the aerosol outlet 105 is provided.
- a pair of throttle parts 154 are provided on both side surfaces of the second flow path part 104B, whereby an aerosol outlet 155 is formed near the stop position of the second flow path part 104B.
- Exhalation discharge ports 106 are provided on both side surfaces of the upper cylindrical portion 152 at a position corresponding to the portion where the throttle portion 154 is provided.
- the restricting portion 154 is located on the inner side of the exhalation exhaust port 106 in the portion where the exhalation exhaust port 106 of the second flow path unit 104B is provided.
- the airflow when the user holds the mouthpiece 150C and inhales the aerosol is as shown in FIG. That is, the aerosol that has flowed into the first flow path portion 104A flows upward, reaches the corner flow path portion 104C, and flows into the second flow path portion 104B and is then discharged from the aerosol outlet 105.
- the aerosol is collected on the upper surface side of the channel wall defining the second channel part 104B. Therefore, the aerosol passes through a position far from the exhalation discharge port 106 in the portion where the exhalation discharge port 106 is provided. Accordingly, negative pressure is generated in the vicinity of the portion where the exhalation exhaust port 106 is provided (portion indicated by region A in FIG. 19), and this causes outside air to be introduced from the exhalation exhaust port 106, so that the aerosol is expelled. Aerosol waste that can be prevented from leaking through the outlet 106 is reliably prevented.
- the exhaled air introduced into the second flow path portion 104B of the mouthpiece 150C by the user exhaling the exhaled air is, as shown in FIG. 20, the second flow path portion 104B. It is discharged to the outside from the exhalation discharge port 106 provided in. At this time, the force with which the aerosol tries to flow into the second flow path portion 104B by the pressure of the compressor 10 is normally greater than the expiratory fluid pressure, so there is no fear that the aerosol leaks from the expiratory outlet 106.
- the mouthpiece 150C for an inhaler as in the present embodiment since the mouthpiece 150C for an inhaler as in the present embodiment is used, it is possible to prevent the aerosol from leaking from the exhalation discharge port 106 regardless of the usage mode. Therefore, the inhalation efficiency can be maintained high without providing an exhalation valve at the exhalation outlet 106, and the number of parts can be reduced, and cleaning and disinfection can be performed. Workability at the time of poisoning can be dramatically improved and the manufacturing cost can be greatly reduced. In addition, since it is not necessary to provide a discharge path for exhalation excluding the aerosol lead-out path 104, which does not require a particularly long throttle part in the flow path, the mouthpiece can be made smaller than before. it can.
- Sarakuko can effectively discharge the exhaled air that has flowed into the lead-out path 104 from the exhaled air discharge port 106, so that it is not necessary to provide an intake valve at the pressure adjustment port 101 provided in the aerosol generating unit. It is also possible to abolish the valve.
- Embodiments 1 to 3 described above a compressor-type inhaler has been described as an example of the inhaler. However, the scope of application of the present invention is not limited to this. Applicable to inhalers and ultrasonic mesh inhalers.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Nozzles (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006298283A AU2006298283B2 (en) | 2005-10-04 | 2006-09-13 | Inhaler and inhaler mouthpiece |
US12/088,628 US9205206B2 (en) | 2005-10-04 | 2006-09-13 | Inhaler and inhaler mouthpiece |
EP06797903.9A EP1932559B1 (en) | 2005-10-04 | 2006-09-13 | Inhalator and mouthpiece for inhalator |
CN2006800365428A CN101277731B (zh) | 2005-10-04 | 2006-09-13 | 吸入器及吸入器用接口管 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005291462A JP4765526B2 (ja) | 2005-10-04 | 2005-10-04 | 吸入器および吸入器用マウスピース |
JP2005-291462 | 2005-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007040025A1 true WO2007040025A1 (ja) | 2007-04-12 |
Family
ID=37906069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/318153 WO2007040025A1 (ja) | 2005-10-04 | 2006-09-13 | 吸入器および吸入器用マウスピース |
Country Status (7)
Country | Link |
---|---|
US (1) | US9205206B2 (ja) |
EP (1) | EP1932559B1 (ja) |
JP (1) | JP4765526B2 (ja) |
CN (1) | CN101277731B (ja) |
AU (1) | AU2006298283B2 (ja) |
RU (1) | RU2383358C2 (ja) |
WO (1) | WO2007040025A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102462879A (zh) * | 2010-11-19 | 2012-05-23 | 深圳市金亿帝科技有限公司 | 一种医用雾化吸入器及其咬嘴 |
CN102462881A (zh) * | 2010-11-19 | 2012-05-23 | 深圳市金亿帝科技有限公司 | 医用雾化吸入器的咬嘴及吸入器 |
US20130032143A1 (en) * | 2010-04-28 | 2013-02-07 | Shinya Tanaka | Nebulizer kit and nebulizer |
RU2558173C2 (ru) * | 2010-04-28 | 2015-07-27 | Омрон Хэлткэа Ко., Лтд. | Распылитель и комплект распылителя |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2394589T3 (es) | 2007-12-14 | 2013-02-04 | Aerodesigns, Inc | Suministro de productos alimenticios transformables en aerosol |
JP5092820B2 (ja) | 2008-03-13 | 2012-12-05 | オムロンヘルスケア株式会社 | ネブライザおよびこれに用いられる吸入補助具 |
EP2349416B1 (en) * | 2008-09-26 | 2015-06-17 | Stamford Devices Limited | A nebuliser system |
JP5556264B2 (ja) * | 2010-03-16 | 2014-07-23 | オムロンヘルスケア株式会社 | ネブライザキットおよびネブライザ |
JP2012000145A (ja) * | 2010-06-14 | 2012-01-05 | Omron Healthcare Co Ltd | ネブライザキットおよびネブライザ |
JP2012000144A (ja) * | 2010-06-14 | 2012-01-05 | Omron Healthcare Co Ltd | ネブライザキットおよびネブライザ |
JP5892933B2 (ja) * | 2010-07-01 | 2016-03-23 | 中村 正一 | ガスミスト吸入器 |
JP5296030B2 (ja) * | 2010-09-24 | 2013-09-25 | パナソニック株式会社 | 電動式吸入器 |
US8567400B2 (en) * | 2010-10-05 | 2013-10-29 | Carefusion 207, Inc. | Non-invasive breathing assistance device with flow director |
BR112013022249B8 (pt) | 2011-03-03 | 2022-10-25 | Impel Neuropharma Inc | Dispositivo de distribuição de droga nasal |
US20130041329A1 (en) * | 2011-08-09 | 2013-02-14 | Church & Dwight Co., Inc. | Nasal rinsing device |
EP2744544B1 (en) * | 2011-10-10 | 2016-12-14 | Koninklijke Philips N.V. | Mouthpiece for delivering nebulized medicament to the airway of a subject |
KR101313993B1 (ko) * | 2012-07-24 | 2013-10-01 | 한국화학연구원 | 약물 흡입 장치 |
KR101373981B1 (ko) | 2012-07-24 | 2014-03-12 | 한국화학연구원 | 약물 흡입 장치 |
US9248252B2 (en) * | 2012-12-19 | 2016-02-02 | Carefusion 303, Inc. | Nebulizer mouthpiece for reducing drug loss |
ITVR20130279A1 (it) * | 2013-12-12 | 2015-06-13 | Elettroplastica S P A | Dispositivo di nebulizzazione di sostanze per aerosol |
JP6361165B2 (ja) * | 2014-02-27 | 2018-07-25 | オムロンヘルスケア株式会社 | ネブライザおよびネブライザキット |
JP1515878S (ja) * | 2014-03-12 | 2015-01-26 | ||
US20150335075A1 (en) * | 2014-05-22 | 2015-11-26 | R.J. Reynolds Tobacco Company | Cartridge and fluid reservoir for a vaporizer |
US10471222B2 (en) | 2014-07-01 | 2019-11-12 | Dance Biopharm Inc. | Aerosolization system with flow restrictor and feedback device |
US11273271B2 (en) | 2014-07-01 | 2022-03-15 | Aerami Therapeutics, Inc. | Aerosolization system with flow restrictor and feedback device |
CN105597199A (zh) * | 2014-09-18 | 2016-05-25 | 郑则广 | 一种保证气雾气体被充分吸入肺部的个体化吸入装置 |
ES2906984T3 (es) | 2014-11-19 | 2022-04-21 | Optinose As | Administración intranasal |
WO2016089981A1 (en) * | 2014-12-04 | 2016-06-09 | Carefusion 2200, Inc. | Breath-actuated nebulizer for medicine inhalation |
DE102015201826A1 (de) * | 2015-02-03 | 2016-08-04 | Robert Bosch Gmbh | Mundstück für eine Vorrichtung zur Messung eines Parameters von Atemluft und Atemluftmessgerät |
CA2975857A1 (en) | 2015-02-04 | 2016-08-11 | Lubby Holdings, LLC | Personal vaporizer with medium and chamber control |
AU2016297677B2 (en) * | 2015-07-20 | 2020-10-08 | Medical Developments International Limited | Inhaler device for inhalable liquids |
US20180207390A1 (en) * | 2015-07-20 | 2018-07-26 | Medical Developments International Limited | Inhaler device for inhalable liquids |
JP7001589B2 (ja) * | 2015-07-20 | 2022-01-19 | メディカル、ディベロップメンツ、インターナショナル、リミテッド | 吸入可能な液体のための吸入器デバイス |
CN108348014B (zh) * | 2015-09-25 | 2023-01-06 | 鲁比控股有限责任公司 | 具有换向气流的个人用汽化器 |
MX2018005336A (es) | 2015-10-30 | 2018-05-17 | Johnson & Johnson Consumer Inc | Nebulizador de aerosol aseptico de dosis unitaria. |
WO2017075318A1 (en) | 2015-10-30 | 2017-05-04 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
CN109310541B (zh) | 2016-02-25 | 2021-10-15 | 阿文提特种材料公司 | 包含增强阻挡性能的添加剂的非织造织物 |
EP3661576B1 (en) * | 2017-08-02 | 2023-04-05 | Medline Industries, LP | Medical nebulizer for fast drug delivery |
TWI674118B (zh) * | 2018-01-31 | 2019-10-11 | 心誠鎂行動醫電股份有限公司 | 霧化器組件及其氣流輔助導引件 |
US11825883B2 (en) | 2018-07-16 | 2023-11-28 | Lubby Holdings, LLC | Personal vaporizer |
CN110141744B (zh) * | 2019-06-30 | 2021-03-23 | 河南省斯科赛斯科技发展有限公司 | 气流雾化器 |
CN112237666B (zh) * | 2019-07-17 | 2022-06-17 | 东莞市爱的仕机电设备有限公司 | 一种雾化器及雾化器用的舌下喷嘴 |
CN110354350B (zh) * | 2019-07-18 | 2021-12-10 | 南京医科大学附属逸夫医院 | 一种改良的雾化器 |
US20220176004A1 (en) * | 2020-12-07 | 2022-06-09 | The Ritedose Corporation | Nebulizer disinfecting system and method of use |
EP4464353A1 (en) * | 2023-05-15 | 2024-11-20 | PARI Pharma GmbH | Inhalation therapy device |
US12090276B1 (en) | 2023-11-15 | 2024-09-17 | Michael R. Minogue | Highly portable gas delivery systems |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0495046U (ja) | 1991-01-08 | 1992-08-18 | ||
JPH05337183A (ja) | 1992-06-10 | 1993-12-21 | Omron Corp | 吸入器の吸入パイプ |
JPH11276587A (ja) * | 1998-01-16 | 1999-10-12 | Pari Gmbh Spezialisten Fuer Effektive Inhalation | 吸入療法装置のためのマウスピ―ス |
JP2004290592A (ja) * | 2003-03-28 | 2004-10-21 | Canon Inc | 液滴吐出装置 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2794332B2 (ja) | 1990-08-08 | 1998-09-03 | ダイセル化学工業株式会社 | アクロレインの製造方法 |
AU6130594A (en) * | 1991-03-05 | 1994-08-15 | Miris Medical Corporation | Method and device for correcting the drift offset of a pressure sensor of a flowmeter |
US5415161A (en) * | 1993-09-15 | 1995-05-16 | Ryder; Steven L. | Intermittant demand aerosol control device |
GB2321419B (en) * | 1997-01-27 | 2001-02-07 | Medic Aid Ltd | Atomizer |
GB2334686B (en) * | 1998-02-26 | 2002-06-19 | Medic Aid Ltd | Nebuliser |
US6615826B1 (en) * | 1999-02-26 | 2003-09-09 | 3M Innovative Properties Company | Slow spray metered dose inhaler |
US6708690B1 (en) * | 1999-09-03 | 2004-03-23 | Respironics, Inc. | Apparatus and method for providing high frequency variable pressure to a patient |
DE19962110C2 (de) * | 1999-12-22 | 2003-06-12 | Pari Gmbh | Inhalationsvernebler mit einstückigem Ventilelement |
US6369725B1 (en) * | 2000-09-26 | 2002-04-09 | International Business Machines Corporation | Method for binary to decimal conversion |
EP1416990A1 (en) * | 2001-08-09 | 2004-05-12 | Glaxo Group Limited | Inhalation device with a pharmaceutical composition |
US7677467B2 (en) * | 2002-01-07 | 2010-03-16 | Novartis Pharma Ag | Methods and devices for aerosolizing medicament |
US7600512B2 (en) * | 2003-07-14 | 2009-10-13 | Vortran Medical Technology 1, Inc. | Inhaler with breath actuated dose counter |
US7270123B2 (en) * | 2003-08-13 | 2007-09-18 | Trudell Medical International | Nebulizer apparatus and method |
WO2005079896A1 (ja) * | 2004-02-19 | 2005-09-01 | Akihiko Miyamoto | リード付喘息治療薬吸入器補助具 |
DE102004009435A1 (de) * | 2004-02-24 | 2005-12-08 | Boehringer Ingelheim International Gmbh | Zerstäuber |
US20060065267A1 (en) * | 2004-03-18 | 2006-03-30 | Pari Innovative Manufacturers, Inc. | Breath enhanced nebulizer with interchangeable top portions |
RU44510U1 (ru) | 2004-10-26 | 2005-03-27 | Белов Леонид Павлович | Ингалятор |
US8056557B2 (en) * | 2005-03-09 | 2011-11-15 | Ric Investments, Llc | Nebulizing drug delivery device with barrier |
-
2005
- 2005-10-04 JP JP2005291462A patent/JP4765526B2/ja active Active
-
2006
- 2006-09-13 US US12/088,628 patent/US9205206B2/en active Active
- 2006-09-13 EP EP06797903.9A patent/EP1932559B1/en active Active
- 2006-09-13 WO PCT/JP2006/318153 patent/WO2007040025A1/ja active Application Filing
- 2006-09-13 CN CN2006800365428A patent/CN101277731B/zh active Active
- 2006-09-13 AU AU2006298283A patent/AU2006298283B2/en not_active Ceased
- 2006-09-13 RU RU2008117423/14A patent/RU2383358C2/ru active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0495046U (ja) | 1991-01-08 | 1992-08-18 | ||
JPH05337183A (ja) | 1992-06-10 | 1993-12-21 | Omron Corp | 吸入器の吸入パイプ |
JPH11276587A (ja) * | 1998-01-16 | 1999-10-12 | Pari Gmbh Spezialisten Fuer Effektive Inhalation | 吸入療法装置のためのマウスピ―ス |
JP2004290592A (ja) * | 2003-03-28 | 2004-10-21 | Canon Inc | 液滴吐出装置 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1932559A4 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130032143A1 (en) * | 2010-04-28 | 2013-02-07 | Shinya Tanaka | Nebulizer kit and nebulizer |
US8651101B2 (en) * | 2010-04-28 | 2014-02-18 | Omron Healthcare Co., Ltd. | Nebulizer kit and nebulizer |
RU2558173C2 (ru) * | 2010-04-28 | 2015-07-27 | Омрон Хэлткэа Ко., Лтд. | Распылитель и комплект распылителя |
CN102462879A (zh) * | 2010-11-19 | 2012-05-23 | 深圳市金亿帝科技有限公司 | 一种医用雾化吸入器及其咬嘴 |
CN102462881A (zh) * | 2010-11-19 | 2012-05-23 | 深圳市金亿帝科技有限公司 | 医用雾化吸入器的咬嘴及吸入器 |
Also Published As
Publication number | Publication date |
---|---|
EP1932559A1 (en) | 2008-06-18 |
AU2006298283A1 (en) | 2007-04-12 |
CN101277731B (zh) | 2010-12-22 |
RU2383358C2 (ru) | 2010-03-10 |
AU2006298283B2 (en) | 2012-03-01 |
JP2007097830A (ja) | 2007-04-19 |
US20100147292A1 (en) | 2010-06-17 |
EP1932559A4 (en) | 2011-08-24 |
RU2008117423A (ru) | 2009-11-10 |
CN101277731A (zh) | 2008-10-01 |
US9205206B2 (en) | 2015-12-08 |
JP4765526B2 (ja) | 2011-09-07 |
EP1932559B1 (en) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4765526B2 (ja) | 吸入器および吸入器用マウスピース | |
EP1859828B1 (en) | Inhaler | |
JP3802929B2 (ja) | ネブライザ用呼吸循環装置 | |
CY1115773T1 (el) | Εισπνευστηρας | |
CN103338804B (zh) | 气雾吸入器 | |
RU2010142290A (ru) | Адаптер дыхательного контура и система проксимальной доставки | |
US20120174917A1 (en) | Press-type medical nebulizer and pressing means thereof | |
EP2744544B1 (en) | Mouthpiece for delivering nebulized medicament to the airway of a subject | |
WO2000072903A1 (en) | Aerosol inhalation device providing improved aerosol delivery | |
US20090050138A1 (en) | Inhaler | |
CN109718433B (zh) | 吸入式雾化器套件 | |
JP4715743B2 (ja) | ネブライザ用吸入補助具 | |
EP3721928B1 (en) | Nebulizer for aerosolizing a liquid with comfortable nose piece | |
EP3459577B1 (en) | Nebulizer for aerosolizing a drug solution with an inner flared-out structure limiting the aerosol waste | |
CN212699974U (zh) | 一种急诊科用吸氧装置 | |
KR20240041082A (ko) | 약액 카트리지 및 휴대용 약액 에어로졸 흡입기 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680036542.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006797903 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12088628 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006298283 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008117423 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2006298283 Country of ref document: AU Date of ref document: 20060913 Kind code of ref document: A |